Clinical Trials Logo
  1. Home
  2. Cholangitis
  3. NCT01148693

Gentamicin in Preventing Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Cholangitis in Non-calculus Stenting

Cholangitis Clinical Trial

Official title:
Comparing Addition of Gentamicin vs. Placebo in Preventing Post ERCP Cholangitis in Non-calculus Stenting

Clinical Trial Summary

Cholangitis is the most prevalent infectious complication of ERCP. Stenting of biliary strictures and stenosis is one of important risk factors for post-ERCP cholangitis. Adding antibiotics to contrast media has proposed in some studies for prevention of cholangitis but remains controversial. In this study we compare effect of adding gentamicin versus placebo in preventing cholangitis in patients who undergone endoscopic stenting for non-calculus strictures and stenosis.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01148693
Study type Interventional
Source Tehran University of Medical Sciences
Contact
Status Completed
Phase N/A
Start date December 2009
Completion date December 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT02917408 - Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Withdrawn NCT02543957 - Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Completed NCT02461147 - Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
Completed NCT01824186 - Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy N/A
Terminated NCT00990366 - Treatment of Biliary Obstruction Using Biliary Stent With or Without Antireflux Valve N/A
Completed NCT02594891 - Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis N/A
Terminated NCT01142921 - The Patency Period of the New Plastic Anti-reflux Biliary Stent N/A
Completed NCT03104582 - Best Biliary Drainage Option in Advanced Klatskin Tumor N/A
Completed NCT04604652 - Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis Phase 2
Terminated NCT02034279 - The INFECIR-2 Albumin Prevention Study Phase 4
Completed NCT04671095 - Single Use ERCP Performance -SURE Study
Recruiting NCT03087656 - Antibiotics to Decrease Post ERCP Cholangitis Phase 4
Completed NCT02098486 - Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP Phase 2
Withdrawn NCT03678480 - A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) Phase 2
Recruiting NCT04216745 - Microbial Analysis in Patients With Cholangitis
Recruiting NCT03133026 - Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation N/A
Terminated NCT02618668 - Haemodynamic Stability of Ketamine/Propofol Admixture "Ketofol" in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography Phase 2
Recruiting NCT01438385 - Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders N/A
Recruiting NCT05750966 - Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis N/A
Recruiting NCT06111872 - Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. Phase 2